相似文献
1
Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma.
Int J Mol Sci. 2018 Oct 3;19(10):3014. doi: 10.3390/ijms19103014.
2
Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
Oncotarget. 2017 May 30;8(22):35783-35791. doi: 10.18632/oncotarget.16206.
3
Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Oncotarget. 2016 Aug 2;7(31):50428-50436. doi: 10.18632/oncotarget.10416.
4
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Br J Cancer. 2014 Aug 12;111(4):749-55. doi: 10.1038/bjc.2014.354. Epub 2014 Jul 1.
5
Prognostic value of β1 integrin expression in colorectal liver metastases.
Int J Clin Exp Pathol. 2013 Dec 15;7(1):288-300. eCollection 2014.
6
Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
PLoS One. 2011 Feb 24;6(2):e16636. doi: 10.1371/journal.pone.0016636.
7
Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
PLoS One. 2015 Mar 20;10(3):e0120724. doi: 10.1371/journal.pone.0120724. eCollection 2015.
8
Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Clin Cancer Res. 2011 Dec 15;17(24):7654-63. doi: 10.1158/1078-0432.CCR-10-2816. Epub 2011 Oct 31.
9
Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.
Tumour Biol. 2014 Oct;35(10):9743-50. doi: 10.1007/s13277-014-2267-4. Epub 2014 Jun 28.
10
A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Int J Mol Sci. 2016 Oct 21;17(10):1755. doi: 10.3390/ijms17101755.
引用本文的文献
1
Effect of Missense Variants on Its Tumor-Suppressive Function.
J Korean Med Sci. 2025 Jul 14;40(27):e146. doi: 10.3346/jkms.2025.40.e146.
2
Metabolomics- and Proteomics-Based Disease Diagnostic Classifier Model for the Prediction and Diagnosis of Colorectal Carcinoma.
J Proteome Res. 2025 Apr 4;24(4):2096-2111. doi: 10.1021/acs.jproteome.5c00010. Epub 2025 Mar 19.
3
Chloride Intracellular Channel Protein 1 Expression and Angiogenic Profile of Liver Metastasis of Digestive Origin.
Curr Issues Mol Biol. 2023 Feb 6;45(2):1396-1406. doi: 10.3390/cimb45020091.
4
Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives.
Cancers (Basel). 2022 Nov 11;14(22):5545. doi: 10.3390/cancers14225545.
5
Diagnostic and therapeutic biomarkers in colorectal cancer: a review.
Am J Cancer Res. 2022 Feb 15;12(2):661-680. eCollection 2022.
6
Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis.
Front Oncol. 2021 Aug 19;11:657984. doi: 10.3389/fonc.2021.657984. eCollection 2021.
7
Core Circadian Clock Proteins as Biomarkers of Progression in Colorectal Cancer.
Biomedicines. 2021 Aug 6;9(8):967. doi: 10.3390/biomedicines9080967.
8
Liver Metastatic Colorectal Tumor Cells Change Their Phenotype During Consecutive Passages on Chick Embryo Chorioallantoic Membrane: Lessons from the Lab to the Clinic.
In Vivo. 2021 Sep-Oct;35(5):2711-2718. doi: 10.21873/invivo.12555.
9
Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review.
Int J Mol Sci. 2020 Jul 24;21(15):5255. doi: 10.3390/ijms21155255.
10
Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Int J Mol Sci. 2019 Oct 3;20(19):4915. doi: 10.3390/ijms20194915.
本文引用的文献
1
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
BMC Cancer. 2018 Jul 20;18(1):752. doi: 10.1186/s12885-018-4639-4.
2
GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
Genes (Basel). 2018 Jul 19;9(7):361. doi: 10.3390/genes9070361.
3
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8.
4
Panitumumab in the treatment of metastatic colorectal cancer, including wild-type RAS, KRAS and NRAS mCRC.
Future Oncol. 2018 Oct;14(24):2437-2459. doi: 10.2217/fon-2017-0711. Epub 2018 May 8.
5
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?
Cancer Biol Ther. 2018 Aug 3;19(8):659-663. doi: 10.1080/15384047.2018.1450117. Epub 2018 Apr 13.
6
Biomarkers in colorectal liver metastases.
Br J Surg. 2018 May;105(6):618-627. doi: 10.1002/bjs.10834. Epub 2018 Mar 26.
7
MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
Jpn J Clin Oncol. 2018 Jul 1;48(7):619-624. doi: 10.1093/jjco/hyy019.
8
and Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers.
Mol Cancer Ther. 2018 May;17(5):1003-1011. doi: 10.1158/1535-7163.MCT-17-0930. Epub 2018 Feb 13.
9
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
BMC Cancer. 2018 Jan 3;18(1):11. doi: 10.1186/s12885-017-3955-4.
10
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers.
J Vis Exp. 2017 Dec 5(130):56686. doi: 10.3791/56686.
Zotero 插件
